Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Novo Nordisk reined in its growth forecasts for the year in its second-quarter financial results update, blaming "persistent use of compounded GLP-1s, slower-than-expected market expansion, and competition." Compounding of semaglutide should have come to a halt in the US since the drug was removed from the FDA list of medicines in short supply, but various companies continue to provide compounded GLP-1s under a loophole that allows the sale of 'personalised' formulations
Drug treatment Liraglutide was from Hoersholm Pharmacy (Hoersholm, Denmark)
This effect likely relates to the peptide's GABAergic and anti-NMDA activities
It was not reported in the Phase 2 trial
Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms
US$ 21.21
US$ 20.96
US$ 27.32
US$ 26.65
US$ 25.18
US$ 27.85
US$ 28.40
US$ 20.29
US$ 28.31
US$ 22.13
US$ 28.26
US$ 20.41
US$ 25.54
